Tacalyx GmbH | WebDisclosure

Basculer en Français

8695	Companies
150593	Keywords
86148	Articles
80762	Press releases

Home
Companies
Tacalyx GmbH

BRIEF

published on 06/11/2024 at 13:05, 11 months 20 days ago

Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics

Seed Financing Tacalyx Cancer Therapeutics TACA Thuja Capital
BRIEF

published on 06/11/2024 at 13:05, 11 months 20 days ago

Tacalyx étend son cycle de financement à plus de 14 millions d'euros pour faire progresser le développement de ses produits thérapeutiques contre le cancer

Financement De Démarrage Tacalyx TACA Thérapie Du Cancer Capitale Thuya
PRESS RELEASE

published on 06/11/2024 at 13:00, 11 months 20 days ago

Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs
Tacalyx extends seed round to over €14 M led by Thuja Capital to advance development of cancer therapeutics targeting TACAs, aiming to create novel treatment options for patients with specificity across solid tumor indications

Seed Round Tacalyx Cancer Therapeutics Thuja Capital TACAs

Accesswire

Published on 06/02/2025 at 10:00, 1 hour 43 minutes ago

The Battery Show Europe 2025 Champions Deep-Dive Learning and Global Dialogues
Published on 06/02/2025 at 01:00, 10 hours 43 minutes ago

Sparta Capital Announces Filing of Interim Financial Statements
Published on 05/31/2025 at 06:16, 2 days 5 hours ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 2 days 8 hours ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 2 days 9 hours ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results

View all ACCESSWIRE

EQS Group

Published on 06/02/2025 at 11:23, 19 minutes ago

Mayr-Melnhof Karton AG: MM closes sale of TANN Group
Published on 06/02/2025 at 11:20, 22 minutes ago

Total Voting Rights
Published on 06/02/2025 at 11:09, 33 minutes ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 06/02/2025 at 11:09, 33 minutes ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 06/02/2025 at 10:29, 1 hour 13 minutes ago

Sandra Schröder joins CHEPLAPHARM’S Management Team as VP Scientific

Les Echos

Published on 05/30/2025 at 22:00, 2 days 13 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 2 days 13 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 2 days 17 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 4 days 12 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 4 days 12 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE